National Cancer Institute; Notice of Meeting, 9820 [08-795]
Download as PDF
9820
Federal Register / Vol. 73, No. 36 / Friday, February 22, 2008 / Notices
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: March 27–28, 2008.
Time: 8 a.m. to 3:30 p.m.
Agenda: Approval of Minutes; Report from
Dr. John Niederhuber; Report on the Office of
Advocacy Relations; Report from Planning &
Office of Governmental & Congressional
Relations OD/NCI. Presentations on
Eliminating Cancer Health Disparities;
Update on CTAC; Update on the NCI
Community Cancer Clinics Program; Reports
from DCLG Working Groups; DCLG Member
Updates; Public Comment; Action Items &
Conclusion.
Place: National Institutes of Health.
Building 31, 31 Center Drive, 6th Floor,
Bethesda, MD 20892.
Contact Person: Barbara Guest, Executive
Secretary, Office Of Advocacy Relations,
National Cancer Institute, National Institutes
of Health, 6116 Executive Blvd., Room 2202,
Bethesda, MD 20892–8324, 301–496–0307,
guestb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
VerDate Aug<31>2005
16:38 Feb 21, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–795 Filed 2–21–08; 8:45 am]
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group, Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: March 18, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Gopal M. Bhatnagar, PhD.,
Scientific Review Administrator, National
Institute of Child Health and Human
Development, National Institutes of Health,
6100 Bldg., Rm., 5B01, Rockville, MD 20852,
(301) 435–6889, bhatnagg@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–791 Filed 2–21–08: 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, MRDD Center
Review.
Date: March 18, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue, NW., Washington, DC
20036.
Contact Person: Norman Chang, PhD.,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, (301) 496–1485,
changn@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–792 Filed 2–21–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
E:\FR\FM\22FEN1.SGM
22FEN1
Agencies
[Federal Register Volume 73, Number 36 (Friday, February 22, 2008)]
[Notices]
[Page 9820]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-795]
[[Page 9820]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer
Liaison Group.
Date: March 27-28, 2008.
Time: 8 a.m. to 3:30 p.m.
Agenda: Approval of Minutes; Report from Dr. John Niederhuber;
Report on the Office of Advocacy Relations; Report from Planning &
Office of Governmental & Congressional Relations OD/NCI.
Presentations on Eliminating Cancer Health Disparities; Update on
CTAC; Update on the NCI Community Cancer Clinics Program; Reports
from DCLG Working Groups; DCLG Member Updates; Public Comment;
Action Items & Conclusion.
Place: National Institutes of Health. Building 31, 31 Center
Drive, 6th Floor, Bethesda, MD 20892.
Contact Person: Barbara Guest, Executive Secretary, Office Of
Advocacy Relations, National Cancer Institute, National Institutes
of Health, 6116 Executive Blvd., Room 2202, Bethesda, MD 20892-8324,
301-496-0307, guestb@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-795 Filed 2-21-08; 8:45 am]
BILLING CODE 4140-01-M